Skip to main content
logo
Beijing Hotgen Biotech Co., Ltd. (SHA:688068)
China flag China · Delayed Price · Currency is CNY
107.03
-6.81 (-5.98%)
May 12, 2026, 3:00 PM CST

Beijing Hotgen Biotech Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
10,11314,3915,5403,6705,6067,224
Market Cap Growth
2.63%159.78%50.94%-34.53%-22.40%197.90%
Enterprise Value
9,06313,3454,5383,0943,9425,855
Last Close Price
113.84162.0061.8440.7360.4374.87
PE Ratio
---126.905.933.31
Forward PE
-33.4033.4033.4033.4033.40
PS Ratio
23.6535.5410.846.701.581.35
PB Ratio
3.905.421.801.091.672.51
P/TBV Ratio
4.245.901.831.111.712.59
P/FCF Ratio
----13.563.22
P/OCF Ratio
----5.732.73
EV/Sales Ratio
21.1932.968.885.651.111.09
EV/EBITDA Ratio
---197.583.332.23
EV/EBIT Ratio
----3.602.28
EV/FCF Ratio
-47.74---9.532.61
Debt / Equity Ratio
0.000.0200.010.010.01
Debt / EBITDA Ratio
---0.610.030.01
Debt / FCF Ratio
----0.100.02
Net Debt / Equity Ratio
-0.47-0.50-0.35-0.18-0.42-0.71
Net Debt / EBITDA Ratio
6.017.8415.36-37.74-1.20-0.78
Net Debt / FCF Ratio
6.3710.3712.111.28-3.44-0.91
Asset Turnover
0.130.120.150.150.942.36
Inventory Turnover
2.472.112.331.458.5611.71
Quick Ratio
6.176.005.043.533.092.96
Current Ratio
6.746.445.484.473.523.43
Return on Equity (ROE)
-10.68%-9.03%-6.08%0.50%29.71%121.66%
Return on Assets (ROA)
-5.54%-4.79%-2.79%-0.76%18.14%70.75%
Return on Invested Capital (ROIC)
-20.72%-14.93%-6.46%-1.93%68.42%359.48%
Return on Capital Employed (ROCE)
-9.80%-8.50%-5.00%-1.30%32.30%88.40%
Earnings Yield
-2.44%-1.50%-3.45%0.79%16.85%30.26%
FCF Yield
-1.88%-0.88%-1.60%-12.58%7.38%31.09%
Dividend Yield
---0.49%-4.51%
Payout Ratio
----32.92%4.27%
Buyback Yield / Dilution
1.25%6.46%-4.59%3.88%0.14%0.12%
Total Shareholder Return
1.25%6.46%-4.59%4.37%0.14%4.63%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.